Toggle light / dark theme

The gene-editing tool has been used in a trial to enhance the blood cells of two patients with cancer.

The trial: The experimental research, under way at the University of Pennsylvania, involves genetically altering a person’s T cells so that they attack and destroy cancer. A university spokesman confirmed it has treated the first patients, one with sarcoma and one with multiple myeloma.

Slow start: Plans for the pioneering study were first reported in 2016, but it was slow to get started. Chinese hospitals, meanwhile, have launched a score of similar efforts. Carl June, the famed University of Pennsylvania cancer doctor, has compared the Chinese lead in employing CRISPR to a genetic Sputnik.

Read more

Oral cancer is known for its high mortality rate in developing countries, but an international team of scientists hope its latest discovery will change that.

Researchers from the University of Otago and the Indian Statistical Institute (ISI), Kolkata, have discovered epigenetic markers that are distinctly different in tissues compared to the adjacent healthy tissues in patients.

Co-author Dr. Aniruddha Chatterjee, of Otago’s Department of Pathology, says finding these biomarkers is strongly associated with patient survival.

Read more

Scientists bring some functions in a pig’s BRAIN ‘back to life’ — four hours after the farm animal died„.


Scientists have been able to partially revive the brains of decapitated pigs that died four hours earlier in a groundbreaking study.

Experts used tubes that pumped a chemical mixture designed to mimic blood into the decapitated heads of 32 pigs to restore circulation and cellular activity.

Gene hacking techniques that were recently used in human cells for the first time could someday let doctors shred up and destroy viruses like herpes or hepatitis B inside human cells, scientists say.

The new technique is called CRISPR-Cas3 — usually, when you hear about CRISPR tech, it’s the Cas9 variety — and Cornell researchers believe it could be used to cure viral diseases, according to a university-published press release.

Read more


“Julie has been associated with SENS since its earliest days: she participated in the first workshop that I organised to discuss it, in 2000, and she was a co-author on the first SENS paper in 2002. We’re delighted to be funding her laboratory at the Buck Institute to explore new ways of eliminating neurofibrillary tangles from neurons of Alzheimer’s sufferers, and at UA2019 we will hear about their initial progress.” says Aubrey de Grey.

https://www.undoing-aging.org/news/dr-julie-k-andersen-to-sp…Qq6fZbArkM #

#undoingaging #sens #foreverhealthy


Videos will be released step by step over the next few weeks as we receive clearance from the individual speakers.


This week we kick it off with Jerry Shay, who is the Vice Chairman of the Department of Cell Biology at The University of Texas Southwestern Medical Center in Dallas, presenting ‘Telomeres and Telomerase in Aging and Cancer‘.

undoing-aging.org/…/jerry-shay-presenting-at-undoing-aging-…

More info on Forever Healthy: forever-healthy.org